Bicocca Open Archive

Logo unimib boa
ALIBERTI, STEFANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.520
EU - Europa 3.078
AS - Asia 1.051
OC - Oceania 12
AF - Africa 8
SA - Sud America 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 12.677
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.356
CN - Cina 674
DE - Germania 629
SE - Svezia 579
UA - Ucraina 505
IE - Irlanda 469
IT - Italia 332
HK - Hong Kong 234
CA - Canada 162
GB - Regno Unito 161
FI - Finlandia 121
AT - Austria 95
VN - Vietnam 70
FR - Francia 63
RU - Federazione Russa 55
IN - India 32
NL - Olanda 23
DK - Danimarca 17
TR - Turchia 14
BE - Belgio 12
JP - Giappone 9
AU - Australia 6
NZ - Nuova Zelanda 6
IR - Iran 5
BG - Bulgaria 4
ES - Italia 4
BR - Brasile 3
EG - Egitto 3
LB - Libano 3
SG - Singapore 3
EU - Europa 2
GR - Grecia 2
IQ - Iraq 2
KR - Corea 2
MX - Messico 2
PT - Portogallo 2
SC - Seychelles 2
A2 - ???statistics.table.value.countryCode.A2??? 1
CH - Svizzera 1
CM - Camerun 1
CO - Colombia 1
ID - Indonesia 1
MD - Moldavia 1
MU - Mauritius 1
NG - Nigeria 1
NO - Norvegia 1
NP - Nepal 1
PL - Polonia 1
RO - Romania 1
TW - Taiwan 1
VE - Venezuela 1
Totale 12.677
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.381
Woodbridge 1.161
Fairfield 865
Houston 766
Jacksonville 565
Dublin 458
Chandler 456
Ashburn 411
Wilmington 363
Seattle 350
Dearborn 346
Cambridge 302
Frankfurt am Main 236
Hong Kong 234
Princeton 225
New York 191
Nanjing 119
Altamura 108
Hangzhou 107
Beijing 99
Lachine 97
Lawrence 95
Milan 94
Vienna 91
Shanghai 72
Nanchang 45
San Diego 39
Shenyang 32
Ottawa 31
Dong Ket 30
Hebei 29
Jiaxing 26
Andover 22
Norwalk 22
Toronto 22
Tianjin 21
Falls Church 20
Helsinki 20
Jinan 19
Guangzhou 18
Ningbo 17
Mountain View 16
London 15
Changsha 14
Fremont 14
Huizen 14
Boardman 11
Brussels 11
Hefei 10
Kunming 10
Chicago 9
Lissone 8
Zhengzhou 8
Kilburn 7
Moscow 6
San Mateo 6
Edmonton 5
Montréal 5
Redmond 5
Rome 5
Taizhou 5
Turin 5
Lappeenranta 4
Nürnberg 4
Phoenix 4
San Francisco 4
University Park 4
Auburn Hills 3
Auckland 3
Bari 3
Campodarsego 3
Cincinnati 3
Groningen 3
Hanoi 3
Jaipur 3
Kiev 3
Laurel 3
Leawood 3
Linköping 3
Los Angeles 3
Messina 3
Monmouth Junction 3
Sofia 3
Virginia Beach 3
Zanjan 3
Adelaide 2
Baotou 2
Basra 2
Beirut 2
Bologna 2
Bonndorf 2
Changchun 2
Chiswick 2
Clearwater 2
Florence 2
Flushing 2
Fort Worth 2
Genoa 2
Hounslow 2
Jesi 2
Totale 9.898
Salva come PNG Salva come JPEG
Nome #
Characterizing non-tuberculous mycobacteria infection in bronchiectasis 265
Impact of age and comorbidity on cause and outcome in community-acquired pneumonia 235
Dyspnea in crackling lungs 205
Influenza A/H1N1 severe pneumonia: Novel morphocytological findings in bronchoalveolar lavage 182
Delirium symptoms during hospitalization predict long-term mortality in patients with severe pneumonia 180
Impact of traffic-related air pollution on pulmonary oxidative stress 178
Diaphragm ultrasonography in the management of patients with amyotrophic lateral sclerosis 175
Non-invasive mechanical ventilation in patients with diffuse interstitial lung diseases 172
Cardiovascular autonomic alterations in hospitalized patients with community-acquired pneumonia 170
A 61-year-old female with chronic cough and purulent sputum 166
A 13-year-old female with shortness of breath and pleuritic chest pain 161
Multidimensional severity assessment in bronchiectasis: An analysis of seven European cohorts 157
Clinical phenotypes in adult patients with bronchiectasis 157
Etiology of non-cystic fibrosis bronchiectasis in adults and its correlation to disease severity 155
Prulifloxacin: A brief review of its potential in the treatment of acute exacerbation of chronic bronchitis 154
Positive end expiratory pressure in acute hypoxemic respiratory failure due to community acquired pneumonia: Do we need a personalized approach? 153
Hospital admission decision for patients with community-acquired pneumonia 150
Mixed community-acquired lower respiratory tract infections 149
Mortality in acute cardiogenic pulmonary edema treated with continuous positive airway pressure 146
The role of lung ultrasound in the diagnosis and follow-up of community-acquired pneumonia 146
Non-tuberculous mycobacteria pulmonary disease: an integrated approach beyond antibiotics 146
Chlamydia pneumoniae and acute aortic syndrome: A call for a multi-institutional study 141
Early administration of the first antimicrobials should be considered a marker of optimal care of patients with community-acquired pneumonia rather than a predictor of outcomes 137
Helmet CPAP vs. oxygen therapy in severe hypoxemic respiratory failure due to pneumonia 136
Contrasting Inflammatory Responses in Severe and Non-severe Community-acquired Pneumonia 130
Pneumonia: how important are local epidemiology and smoking habits? 129
Strategic targets of essential host-pathogen interactions 129
Compliance with anti-H1N1 vaccine among healthcare workers and general population 129
Microbiological Diagnosis and Antibiotic Therapy in Patients with Community-Acquired Pneumonia and Acute COPD Exacerbation in Daily Clinical Practice: Comparison to Current Guidelines 129
Comorbidities and the risk of mortality in patients with bronchiectasis: an international multicentre cohort study 129
Non-invasive continuous positive airway pressure in monolateral lung transplant patient with pneumonia and IPF 128
Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study 128
The management of community-acquired pneumonia in the elderly 124
COPD and bronchiectasis: Phenotype, endotype or co-morbidity? 124
Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: A multinational point prevalence study of hospitalised patients 124
Prevalence and risk factors for Enterobacteriaceae in patients hospitalized with community-acquired pneumonia 124
Criteria for clinical stability in hospitalised patients with community-acquired pneumonia 123
Nontuberculous Mycobacteria in Noncystic Fibrosis Bronchiectasis 123
Phenotyping in Bronchiectasis: Are we moving towards a personalized medicine? 123
Should health care systems and health care providers implement a new pathway for hospitalized patients with community-acquired pneumonia? 122
100 years of respiratory medicine: pneumonia 121
Noninvasive ventilation or continuous positive airway pressure in pulmonary edema patients with respiratory acidosis? Look at the bicarbonates 121
Predicting Mycobacterium tuberculosis in patients with community-acquired pneumonia 120
Geriatric multidimensional assessment for elderly patients with acute respiratory diseases 120
The bronchiectasis severity index. An international derivation and validation study 120
Phenotyping community-acquired pneumonia according to the presence of acute respiratory failure and severe sepsis 119
Impact of exacerbations in the natural course of COPD 119
Thrombocytopenia and thrombocytosis at time of hospitalization predict mortality in patients with community-acquired pneumonia 118
Usefulness of simplified acute physiology score II in predicting mortality in patients admitted to an emergency medicine ward 118
Microbiological testing of adults hospitalised with community-acquired pneumonia: an international study 118
Long-term azithromycin use in patients with chronic obstructive pulmonary disease and tracheostomy 117
Severe asthma exacerbation: role of acute Chlamydophila pneumoniae and Mycoplasma pneumoniae infection 116
The Clinical and Economic Impact of Exacerbations of Chronic Obstructive Pulmonary Disease: A Cohort of Hospitalized Patients 116
Serum and exhaled breath condensate inflammatory cytokines in community-acquired pneumonia: a prospective cohort study 115
Acidemia does not affect outcomes of patients with acute cardiogenic pulmonary edema treated with continuous positive airway pressure 113
Stratifying Risk Factors for Multidrug-Resistant Pathogens in Hospitalized Patients Coming From the Community With Pneumonia 113
The role of biomarkers in low respiratory tract infections 112
Early application of non-invasive continuous positive airway pressure in acute respiratory distress syndrome due to a drug overdose: a case report 111
Duration of antibiotic therapy in hospitalised patients with community-acquired pneumonia 111
Antibiotics as immunomodulant agents in COPD 111
The effectiveness of the polysaccharide pneumococcal vaccine for the prevention of hospitalizations due to Streptococcus pneumoniae community-acquired pneumonia in the elderly differs between the sexes: results from the Community-Acquired Pneumonia Organization (CAPO) international cohort study 111
Where are the acutely ill best cared for and who should look after them? 110
The management of patients with community-acquired pneumonia beyond antibiotic therapy 110
Pneumonia in the community caused by multidrug-resistant organisms: keep working on probabilistic scores 110
Validation of the 3CPO-score in a prospective cohort of Acute Cardiogenic Pulmonary Edema (ACPE) patients 110
Azithromycin and lower respiratory tract infections 107
Low CURB-65 is of limited value in deciding discharge of patients with community-acquired pneumonia 107
Clinical and economical impact of exacerbations of chronic obstructive pulmonary disease (COPD): a two year study 107
Pneumococcal Vaccine and Patients with Pulmonary Diseases 107
Nosocomial transmission of carbapenem-resistant Klebsiella pneumoniae in an Italian university hospital: a molecular epidemiological study 107
Do prognostic factors help physicians in predicting legionellosis' respiratory complications? 105
Individualizing duration of antibiotic therapy in community-acquired pneumonia 105
Chlamydophila pneumoniae 104
Understanding the roles of cytokines and neutrophil activity and neutrophil apoptosis in the protective versus deleterious inflammatory response in pneumonia 103
Acute exacerbation of COPD: application of evidence-based guidelines 103
Management of nontuberculous mycobacterial infection in the elderly 103
Cardiac diseases complicating community-acquired pneumonia 102
Are multi-drug resistant (MDR) pathogens related to higher mortality in pneumonia? 102
International prevalence and risk factors evaluation for drug-resistant Streptococcus pneumoniae pneumonia 101
Is it time for a "pneumo-geriatrician" for frail old patients with respiratory diseases? 100
Incidence, etiology, timing, and risk factors for clinical failure in hospitalized patients with community-acquired pneumonia 99
Clinical Stability versus Clinical Failure in Patients with Community-Acquired Pneumonia 99
Chlamydia pneumoniae and Mycoplasma pneumoniae 96
Acute myocardial infarction versus other cardiovascular events in communityacquired pneumonia 96
Clinical applications of azithromycin microspheres in respiratory tract infections 95
The pneumonia severity index and the CRB-65 in cancer patients with community-acquired pneumonia 94
Telithromycin in lower respiratory tract infections 93
Acute myocardial infarction in hospitalized patients with community-acquired pneumonia 93
Association between time to clinical stability and outcomes after discharge in hospitalized patients with community-acquired pneumonia 90
Healthcare-associated pneumonia: where do we go next? 87
Predicting mortality in hospitalized patients with 2009 H1N1 influenza pneumonia 86
Highlights on the appropriate use of fluoroquinolones in respiratory tract infections 84
Acute effects of positive end-expiratory pressure on left ventricle diastolic function in healthy subjects 83
The role of neutropenia on outcomes of cancer patients with community-acquired pneumonia 82
Chlamydophila pneumoniae induces a sustained airway hyperresponsiveness and inflammation in mice 81
Non-invasive-ventilation in H1N1 acute respiratory failure in emergency department: A case series 81
Multidrug-resistant pathogens in hospitalised patients coming from the community with pneumonia: a European perspective 80
Helmet continuous positive airway pressure vs oxygen therapy to improve oxygenation in community-acquired pneumonia: a randomized, controlled trial 79
The changing microbiologic epidemiology of community-acquired pneumonia 78
“Normotension” on admission to the emergency department affects outcome of patients with acute cardiogenic pulmonary edema (ACPE) 73
Totale 12.226
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.390
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.390
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019702 0 0 0 0 0 0 0 0 0 0 364 338
2019/20202.915 400 219 231 223 266 332 375 220 288 118 175 68
2020/20211.586 134 84 165 168 108 82 145 139 146 219 69 127
2021/20221.059 51 102 104 90 52 103 55 61 64 86 93 198
2022/20231.833 250 532 224 133 92 315 9 90 133 4 25 26
2023/20241.131 35 32 47 31 172 335 254 57 153 15 0 0
Totale 12.904